Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Ioannidis, Ioannis  [Clear All Filters]
Journal Article
Koufakis, T., Ioannidis I., Zebekakis P., & Kotsa K. (2018).  The beta-cell death in long-term type 2 diabetes mellitus: never say never again.. Minerva Endocrinol.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece. Clinical Drug Investigation. 3831184061314132015410373121437191919154637191436(511Suppl 2518942221193773988), 417 - 426.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.. Clin Drug Investig. 38(5), 417-426.
Ioannidis, I. (2014).  Diabetes treatment in patients with renal disease: Is the landscape clear enough?. World J Diabetes. 5(5), 651-8.
Achimastos, A., Alexandrides T., Alexopoulos D., Athyros V., Bargiota A., Bilianou E., et al. (2016).  Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.. Hormones (Athens). 15(1), 8-14.
Thomopoulos, C., Spanoudi F., Kyriazis I., Anastasopoulos I., & Ioannidis I. (2013).  Metabolic effects of renal denervation.. Curr Clin Pharmacol. 8(3), 206-11.
Georgiopoulos, G., Tsioufis C., Tsiachris D., Dimitriadis K., Kasiakogias A., Lagiou F., et al. (2016).  Metabolic syndrome, independent of its components, affects adversely cardiovascular morbidity in essential hypertensives.. Atherosclerosis. 244, 66-72.
Bistola, V., Lambadiari V., Dimitriadis G., Ioannidis I., Makrilakis K., Tentolouris N., et al. (2018).  Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.. Heart Fail Rev. 23(3), 377-388.
Bistola, V., Lambadiari V., Dimitriadis G., Ioannidis I., Makrilakis K., Tentolouris N., et al. (2018).  Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. Heart Failure Reviews. 377 - 388.
Voukali, M., Kastrinelli I., Stragalinou S., Tasiopoulou D., Paraskevopoulou P., Katsilambros N., et al. (2014).  Study of postprandial lipaemia in type 2 diabetes mellitus: exenatide versus liraglutide.. J Diabetes Res. 2014, 304032.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές